6th Age-Related Disease Therapeutics Summit
Join the global biopharma community at the 6th Age-Related Disease Therapeutics Summit, taking place January 27–29, 2026, in San Francisco. This industry-leading event is your gateway to the latest breakthroughs in aging biology, translational science, and clinical innovation, designed to accelerate the development of safe, effective, and regulatory-compliant therapeutics targeting age-related diseases.
With aging biology now at a critical inflection point, the summit arrives at a time of unprecedented momentum. Landmark deals like Novartis’ $550M alliance with BioAge Labs and Chugai’s $250M AI-driven partnership signal a surge of investment and clinical activity. Aging-targeted therapeutics, from senolytics and partial reprogramming to repurposed GLP-1s, are stepping out of the lab and into the clinic, and this summit offers a dedicated platform to harness that momentum.
Expect to hear from over 20 world-class speakers, including:
- Jeremiah Bearss, VP of Clinical Development at Biolexis Therapeutics
- Peng Leong, Head of Brain Aging & Chief Business Officer at BioAge Labs
- Alexander Pickett, Managing Director at Juvenescence
- Anne-Ulrike Trendelenburg, Executive Director at Novartis
- Joseph Rayman, Principal Investigator at Columbia University
These thought leaders will share cutting-edge insights into drug development strategies, biomarker innovation, delivery mechanisms, and regulatory pathways. Whether you're advancing early-stage assets or scaling clinical programs, the summit provides actionable intelligence to help you navigate translational bottlenecks and unlock therapeutic potential.
The agenda features 3 content-packed days, 5+ hours of dedicated networking, and 2 interactive workshops focused on regulatory, C-suite, and investor perspectives. Dive into case studies, investor panels, and translational science sessions that explore how aging biology is being transformed into real-world therapies.
This is a must-attend event for biopharma professionals, academic researchers, and solution providers committed to pioneering longevity and improving healthspan.
View the full agenda here to learn more about the summit: https://ter.li/n1qknq
